Leuprolide Acetate
Product Images NDC 83634-454

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 83634-454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Leu0f 0000 01)

Chemical structure diagram of Leuprolide Acetate showing its molecular composition and specific arrangement of atoms, including carbon, hydrogen, nitrogen, and oxygen atoms in a complex peptide chain.*

FDA Label Image

Figure A (Leu0f 0000 02)

An instructional black-and-white illustration showing a hand holding a syringe, with the other hand drawing liquid from a vial into the syringe. The image depicts the preparation of an injectable dose, possibly relating to Leuprolide Acetate.*

FDA Label Image

Figure B (Leu0f 0000 03)

An instructional black-and-white illustration showing hands being washed under running water from a faucet. Soap lather is visible on the hands.*

FDA Label Image

Figure C (Leu0f 0000 04)

An instructional black-and-white illustration showing a hand peeling or removing the protective cap from the top of a vial bottle. This image depicts the opening step for accessing the contents of a vial, commonly used for injectable drugs such as Leuprolide Acetate by Avenacy, LLC.*

FDA Label Image

Figure D (Leu0f 0000 05)

An instructional illustration showing hands manipulating a small vial or container, possibly to open or prepare it. The image is a black and white line drawing focusing on the fingers holding the vial's cap and body, demonstrating the removal or attachment process.*

FDA Label Image

Figure E (Leu0f 0000 06)

Illustration showing a hand holding a prefilled syringe with a needle attached. An arrow indicates the direction to push the plunger to administer the injection.*

FDA Label Image

Figure F (Leu0f 0000 07)

An instructional illustration showing a person removing a needle cap from a syringe, preparing it for injection. The image focuses on the hands holding the needle and the cap.*

FDA Label Image

Figure G (Leu0f 0000 08)

An instructional illustration showing two hands preparing a syringe by drawing liquid from a vial. One hand holds the vial steady while the other pulls back the syringe plunger to withdraw the medication.*

FDA Label Image

Figure H (Leu0f 0000 09)

A black and white instructional illustration showing a close-up of hands handling a syringe and vial. One hand holds a vial steady while the other hand inserts the needle of a syringe into the vial's rubber stopper. This image demonstrates the preparation of an injection.*

FDA Label Image

Figure I (Leu0f 0000 10)

An instructional illustration showing a person drawing liquid from a vial into a syringe, with the vial held upside down. The image likely demonstrates proper technique for preparing an injection.*

FDA Label Image

Figure J (Leu0f 0000 11)

An instructional illustration depicting a hand administering an injection into the skin on the forearm using a syringe, while the other hand stabilizes the injection site.*

FDA Label Image

Figure K (Leu0f 0000 12)

An instructional illustration showing two hands performing a subcutaneous injection. One hand holds a syringe with the needle inserted at an angle into the skin, while the other hand stretches the skin around the injection site.*

FDA Label Image

Figure L (Leu0f 0000 13)

An instructional-style black-and-white illustration depicting a hand disposing of a syringe into a sharps container. The container is square with a wide opening at the top and a label on its front side, representing safe disposal of injectable medical waste.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Leu0f 0000 14)

Leuprolide Acetate Injection 14 mg per 2.8 mL multi-dose vial label by Avenacy, LLC. It specifies 1 mg per 0.2 mL dosage, for subcutaneous injection. The label includes storage instructions, sterile nonpyrogenic status, and manufacturer details including Avenacy Inc., Schaumburg, IL, made in Taiwan.*

FDA Label Image

Package Label – Principal Display Panel – Carton (Leu0f 0000 15)

Leuprolide Acetate 14 mg per 2.8 mL injection packaging label for one multi-dose vial by Avenacy, LLC. The label shows the proprietary name, dosage strength (14 mg per 2.8 mL, 1 mg per 0.2 mL), route of administration (subcutaneous injection), NDC 83634-452, and storage instructions. The label includes manufacturer information and standard drug container warnings.*

FDA Label Image

Package Label – Principal Display Panel – Kit (Leu0f 0000 16)

Leuprolide Acetate Injection 14 mg per 2.8 mL (1 mg per 0.2 mL) 14 Day Patient Administration Kit packaging label by Avenacy, LLC. The label indicates this is for subcutaneous injection and includes storage and handling information. The label displays the product name, strength, dosage form, and labeler details along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.